Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TERIZOL: Teriparatide vs Zoledronic Acid in Osteoporosis
NCT01153425Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Jul 2008
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in osteoporosis comparing Teriparatide with Zoledronic Acid (2 arms). Primary endpoint: Percentage of Change in Trabecular Surface-to-curve Ratio at 12 months. Started Jul 2008; status: completed.
02
Drugs
teriparatidezoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT01153425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01153425.